Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

Roche gets USFDA nod for Columvi to treat relapsed or refractory diffuse large B cell lymphoma

Ruchika Sharma18 Jun 2023 2:42 PM IST

Columvi is a CD20xCD3 T-cell-engaging bispecific antibody designed to target CD3 on the surface of T-cells and CD20 on the surface of B-cells.

Takeda, HUTCHMED gets EMA validation for marketing authorization application for Fruquintinib for Metastatic Colorectal Cancer

Ruchika Sharma18 Jun 2023 12:15 PM IST

Osaka: Takeda and HUTCHMED (China) Limited have announced that the European Medicines Agency (EMA) has validated and accepted for regulatory...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Prometheus Biosciences now wholly-owned subsidiary of Merck

Ruchika Sharma18 Jun 2023 10:00 AM IST

Under the terms of the acquisition agreement, Merck, through a subsidiary, has acquired all outstanding shares of Prometheus for USD 200.00 per share...

Torrent Pharma Appoints Former Cipla Global CTO Geena Malhotra as Chief Technology Officer

USFDA issues EIR for Torrent Pharma Bileshwarpura facility

Ruchika Sharma17 Jun 2023 4:17 PM IST

Ahmedabad: Torrent Pharma has recently announced that the US Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR)...

CDPQ divests 0.89 percent stake in Piramal Pharma for Rs 100 crore

Ruchika Sharma17 Jun 2023 1:30 PM IST

Vanguard Group acquired more than 62 lakh shares of Piramal Pharma at an average price of Rs 94.71 per share, while other buyer(s) identity is not...

Dr Reddys Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, Europe

USFDA inspection: Dr Reddy's Labs gets zero obervations for Bollaram facility, EIR for Srikakulam facility

Ruchika Sharma17 Jun 2023 12:10 PM IST

Hyderabad: Dr Reddy's Labs has announced that the United States Food & Drug Administration (USFDA) has completed a GMP inspection at the...

Coherus resolves part of dispute with AbbVie over Humira biosimilar

Ruchika Sharma17 Jun 2023 11:00 AM IST

Coherus BioSciences said on Thursday it had agreed to retract a restraining order against AbbVie as the two fight over the terms of launching a...

Expanded age indication for GSK’s AREXVY

USFDA extends review period of GSK Momelotinib by three months

Ruchika Sharma17 Jun 2023 10:00 AM IST

London: GSK plc has announced that the US Food and Drug Administration (FDA) has extended the review period of the new drug application (NDA) for...

Fortis to onboard new 550-bed super specialty hospital in Lucknow

Fortis Healthcare fund diversion case: SEBI issues demand notices to 4 entities

Ruchika Sharma16 Jun 2023 4:06 PM IST

In four fresh notices dated June 9, SEBI directed them to pay Rs 4.56 crore, which includes interest and recovery cost, within 15 days.

UP Govt preparing draft of Pharmaceutical Industry Policy 2023

Ruchika Sharma16 Jun 2023 2:30 PM IST

According to the policy, the Yogi government would provide a 50 per cent interest for a maximum of 7 years on the loan received from a bank for the...

Natco Pharma net profit down 23.44 percent at Rs 517.9 crore in Q2

Natco Pharma Vizag facility gets EIR from USFDA

Ruchika Sharma16 Jun 2023 1:30 PM IST

Hyderabad: Natco Pharma Limited has announced the successful closure of inspection and received Establishment Inspection Report (EIR) from the...

Natco Pharma gets 7 USFDA observations for Kothur Pharma Division

Laurus Labs gets USFDA EIR for Visakhapatnam facility

Ruchika Sharma16 Jun 2023 12:30 PM IST

Hyderabad: Laurus Labs has announced that the Company has received the Establishment Inspection Report (EIR) from the United States Food &...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok